---
schema_version: "secwatch.filing_event.v1"
accession: "0001321732-25-000010"
form_type: "8-K"
ticker: "PEN"
cik: "0001321732"
company_name: "Penumbra Inc"
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T14:46:36.902649+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Penumbra Q4 adjusted revenue $321.3M (+13%); U.S. thrombectomy up 27%

## Summary
- Adjusted revenue (excl. Italian payback) Q4 $321.3M, up 12.9% YoY; reported revenue $315.5M (+10.8%).
- GAAP net income Q4 $33.7M (10.7% margin); full-year net income $14.0M.
- Adjusted EBITDA Q4 $63.7M (19.8% margin); full-year $171.0M (14.2% margin).
- U.S. thrombectomy products grew 27.3% in Q4; international thrombectomy revenue declined 13.9% adjusted.
- Full-year adjusted revenue $1,200.4M, up 13.4% YoY.

## SEC filing metadata
- accession: 0001321732-25-000010
- form_type: 8-K
- ticker: PEN
- cik: 0001321732
- company_name: Penumbra Inc
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321732/000132173225000010/0001321732-25-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321732/000132173225000010/pen-20250218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001321732-25-000010
- JSON: https://secwatch.observer/filing/0001321732-25-000010.json
- Plain text: https://secwatch.observer/filing/0001321732-25-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.